{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:29:30Z","timestamp":1790828970198,"version":"4.1.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T00:00:00Z","timestamp":1443744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1005184","type":"journal-article","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T18:14:08Z","timestamp":1443809648000},"page":"e1005184","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["The Suramin Derivative NF449 Interacts with the 5-fold Vertex of the Enterovirus A71 Capsid to Prevent Virus Attachment to PSGL-1 and Heparan Sulfate"],"prefix":"10.1371","volume":"11","author":[{"given":"Yorihiro","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel P.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hafenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Bergelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,10,2]]},"reference":[{"issue":"11","key":"ref1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"T Solomon","year":"2010","journal-title":"The Lancet Infectious Diseases"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(13)70342-6","article-title":"Hand, foot, and mouth disease in China, 2008\u201312: an epidemiological study","volume":"14","author":"W Xing","year":"2014","journal-title":"The Lancet Infectious Diseases"},{"issue":"9882","key":"ref3","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"FC Zhu","year":"2013","journal-title":"Lancet"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children","volume":"370","author":"R Li","year":"2014","journal-title":"The New England Journal of Medicine"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"F Zhu","year":"2014","journal-title":"The New England Journal of Medicine"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJMp1400601","article-title":"Enterovirus vaccines for an emerging cause of brain-stem encephalitis","volume":"370","author":"PC McMinn","year":"2014","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1442-200X.2006.02198.x","article-title":"Critical management in patients with severe enterovirus 71 infection","volume":"48","author":"JN Wang","year":"2006","journal-title":"Pediatrics international: official journal of the Japan Pediatric Society"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ppul.10258","article-title":"Pulmonary edema of enterovirus 71 encephalomyelitis is associated with left ventricular failure: implications for treatment","volume":"35","author":"YC Fu","year":"2003","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s00134-009-1739-2","article-title":"Extracorporeal life support for treatment of children with enterovirus 71 infection-related cardiopulmonary failure","volume":"36","author":"SL Jan","year":"2010","journal-title":"Intensive Care Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nm.1992","article-title":"Scavenger receptor B2 is a cellular receptor for enterovirus 71","volume":"15","author":"S Yamayoshi","year":"2009","journal-title":"Nature Medicine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nm.1961","article-title":"Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71","volume":"15","author":"Y Nishimura","year":"2009","journal-title":"Nature Medicine"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1128\/JVI.02226-12","article-title":"Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor","volume":"87","author":"CW Tan","year":"2013","journal-title":"J Virol"},{"issue":"22","key":"ref13","doi-asserted-by":"crossref","first-page":"11809","DOI":"10.1128\/JVI.00297-11","article-title":"Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity","volume":"85","author":"SL Yang","year":"2011","journal-title":"J Virol"},{"key":"ref14","article-title":"Cell surface vimentin is an attachment receptor for enterovirus 71","author":"N Du","year":"2014","journal-title":"J Virol"},{"key":"ref15","article-title":"Cell surface nucleolin facilitates enterovirus 71 binding and infection","author":"PY Su","year":"2015","journal-title":"J Virol"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"e1001174","DOI":"10.1371\/journal.ppat.1001174","article-title":"Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection","volume":"6","author":"Y Nishimura","year":"2010","journal-title":"PLoS Pathog"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"e1003511","DOI":"10.1371\/journal.ppat.1003511","article-title":"Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction","volume":"9","author":"Y Nishimura","year":"2013","journal-title":"PLoS Pathog"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1099\/vir.0.2008\/002915-0","article-title":"Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity","volume":"89","author":"M Arita","year":"2008","journal-title":"The Journal of General Virology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/978-1-4614-7651-1_2","article-title":"Picornavirus entry","volume":"790","author":"JM Bergelson","year":"2013","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1073\/pnas.95.1.346","article-title":"Gsalpha-selective G protein antagonists","volume":"95","author":"M Hohenegger","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1042\/bj0400119","article-title":"Studies on suramin (Antrypol: Bayer 205): 5. The combination of the drug with the plasma and other proteins","volume":"40","author":"HM Dewey","year":"1946","journal-title":"The Biochemical Journal"},{"issue":"9","key":"ref22","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1074\/jbc.M111.301622","article-title":"Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2","volume":"287","author":"P Chen","year":"2012","journal-title":"J Biol Chem"},{"issue":"21","key":"ref23","doi-asserted-by":"crossref","first-page":"11363","DOI":"10.1128\/JVI.01926-13","article-title":"A strain-specific epitope of enterovirus 71 identified by cryo-electron microscopy of the complex with fab from neutralizing antibody","volume":"87","author":"H Lee","year":"2013","journal-title":"J Virol"},{"issue":"26","key":"ref24","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1016\/j.vaccine.2011.04.010","article-title":"Identification and characterization of a cross-neutralization epitope of enterovirus 71","volume":"29","author":"CC Liu","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1128\/AAC.36.1.100","article-title":"In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity","volume":"36","author":"K Andries","year":"1992","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.3390\/molecules18033630","article-title":"Synthesis and antiviral activity of N-phenylbenzamide derivatives, a novel class of enterovirus 71 inhibitors","volume":"18","author":"XY Ji","year":"2013","journal-title":"Molecules"},{"key":"ref27","first-page":"1","article-title":"Suramin inhibits EV71 infection","volume":"103C","author":"Y Wang","year":"2013","journal-title":"Antiviral Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1038\/emi.2014.60","article-title":"The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection\u2014suramin inhibits EV71 infection in vitro and in vivo","volume":"3","author":"P Ren","year":"2014","journal-title":"Emerging Microbes & Infections"},{"key":"ref29","article-title":"Tropical Infectious Diseases","author":"RD Pearson","year":"2011"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1212\/WNL.40.6.954","article-title":"Suramin-induced polyneuropathy","volume":"40","author":"RV La Rocca","year":"1990","journal-title":"Neurology"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jmv.2209","article-title":"Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71","volume":"67","author":"N Nagata","year":"2002","journal-title":"J Med Virol"},{"issue":"14","key":"ref32","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.1128\/JVI.00503-11","article-title":"Single amino acid changes in the virus capsid permit coxsackievirus B3 to bind decay-accelerating factor","volume":"85","author":"J Pan","year":"2011","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/327482a0","article-title":"Myristylation of picornavirus capsid protein VP4 and its structural significance","volume":"327","author":"M Chow","year":"1987","journal-title":"Nature"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1073\/pnas.91.13.6245","article-title":"Decay-accelerating factor, a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses","volume":"91","author":"JM Bergelson","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ejmech.2004.01.007","article-title":"Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist","volume":"39","author":"MU Kassack","year":"2004","journal-title":"European Journal of Medicinal Chemistry"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1128\/JVI.67.11.6847-6852.1993","article-title":"Infection by echoviruses 1 and 8 depends on the \u03b12 subunit of human VLA-2","volume":"67","author":"JM Bergelson","year":"1993","journal-title":"J Virol"},{"key":"ref37","unstructured":"Molecular Operating Environment (MOE). 2014.09. Chemical Computing Group Inc., 1010 Sherbooke St. West, Suite 910, Montreal, QC, Canada, H3A 2R. 2014."},{"issue":"6086","key":"ref38","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.1218713","article-title":"Crystal structure of human enterovirus 71","volume":"336","author":"P Plevka","year":"2012","journal-title":"Science"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1005184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T04:19:30Z","timestamp":1599625170000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1005184"}},"subtitle":[],"editor":[{"given":"Timothy L.","family":"Tellinghuisen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,2]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1005184","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,2]]}}}